FDA inspection
DIABETIC CAPITAL US Llc: FDA inspection ending Feb 24, 2000
FDA inspection 18574 · Official Action Indicated (OAI) · Alhambra, CA
Key facts
| Inspection ID | 18574 |
|---|---|
| Firm | DIABETIC CAPITAL US Llc |
| FEI number | 3002799794 |
| Address | 1286 S Garfield Ave |
| City | Alhambra |
| State | CA |
| ZIP | 91801-5036 |
| Fiscal year | 2000 |
| Inspection end date | Feb 24, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Food Compos, Stds, Labeling & Economics|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs |
| Product type | Drugs, Food/Cosmetics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data